Corcept Therapeutics Incorporated · NASDAQ:CORT
Mokari Atabak sold 40,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Jun 1 to Jun 2, 2026 · Filed Jun 3, 2026
From Jun 1 to Jun 2, 2026, Mokari Atabak (Chief Financial Officer) sold 40,000 Corcept Therapeutics Incorporated shares at US$70.00 for US$2.8M under a trading plan, leaving 16,130 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$70.00
- Value
- US$2.8M
- Holding after
- 16,130 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 40,000 | US$19.26 | 55,257 | Direct |
| Jun 1, 2026 | Common Stock | Sale | 40,000 | US$70.00 | 15,257 | Direct |
| Jun 1, 2026 | Common Stock | Award | 634 | US$70.44 | 15,891 | Direct |
| Jun 1, 2026 | Common Stock | Award | 634 | 16,525 | Direct | |
| Jun 2, 2026 | Common Stock | Shares withheld for tax | 395 | US$70.44 | 16,130 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Mokari Atabak
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Mokari Atabak · Sep 3, 2026
- Form 4 · Mokari Atabak · Aug 3, 2026
- Form 4 · Mokari Atabak · Jul 17, 2026
- Form 4 · Mokari Atabak · Jun 17, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026